Calmark Sweden AB logo

CALMA B BTU - Calmark Sweden AB News Story

SEK50 0.0  0.0%

Last Trade - 03/01/20

Sector
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1782

BRIEF-Calmark Sweden: Products For Biomarkers, LDH And Glucose Will Not Obtain CE Conformity Markings Until Q1 2020

Fri 18th October, 2019 2:39pm
Oct 18 (Reuters) - Calmark Sweden AB  CALMAb.TE :
    * CALMARK EXTENDS THE TIME PLAN FOR CE-MARK OF THE
BIOMARKERS LDH
AND GLUCOSE - MARKET LAUNCH AS ACCORDING TO PLAN
    * ANNOUNCES TODAY THAT COMPANY'S PRODUCTS FOR BIOMARKERS,
LDH AND
GLUCOSE, WILL NOT OBTAIN THEIR CE CONFORMITY MARKINGS UNTIL Q1
OF 2020, MARKET LAUNCH OF PRODUCTS WILL NOT BE AFFECTED
    * COMPANY HAS FOCUSED ITS EFFORTS ON FIRST BIOMARKER,
BILIRUBIN,
WHOSE CE-MARK IS ON SCHEDULE, AND ON RAMPING UP PRODUCTION LINES
TO FACILITATE MARKET LAUNCH

Source text for Eikon:  ID:nWkr9kZsqF 
Further company coverage:  CALMAb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.